Phio Pharmaceuticals Corp. (PHIO)

Phio Pharmaceuticals Statistics

Total Valuation

PHIO has a market cap or net worth of $14.64 million. The enterprise value is -$6.39 million.

Market Cap	14.64M
Enterprise Value	-6.39M

Important Dates

The last earnings date was Thursday, March 5, 2026, after market close.

Earnings Date	Mar 5, 2026
Ex-Dividend Date	n/a

Share Statistics

PHIO has 11.62 million shares outstanding. The number of shares has increased by 659.91% in one year.

Current Share Class	11.62M
Shares Outstanding	11.62M
Shares Change (YoY)	+659.91%
Shares Change (QoQ)	+71.14%
Owned by Insiders (%)	0.60%
Owned by Institutions (%)	8.20%
Float	11.55M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	0.73
P/TBV Ratio	0.73
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 16.03

Current Ratio	16.03
Quick Ratio	15.69
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -69.95% and return on invested capital (ROIC) is -46.34%.

Return on Equity (ROE)	-69.95%
Return on Assets (ROA)	-42.33%
Return on Invested Capital (ROIC)	-46.34%
Return on Capital Employed (ROCE)	-45.76%
Weighted Average Cost of Capital (WACC)	9.26%
Revenue Per Employee	n/a
Profits Per Employee	-$1.45M
Employee Count	6
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -3.15% in the last 52 weeks. The beta is 0.91, so PHIO's price volatility has been similar to the market average.

Beta (5Y)	0.91
52-Week Price Change	-3.15%
50-Day Moving Average	1.13
200-Day Moving Average	1.73
Relative Strength Index (RSI)	55.45
Average Volume (20 Days)	402,683

Short Selling Information

The latest short interest is 585,794, so 5.04% of the outstanding shares have been sold short.

Short Interest	585,794
Short Previous Month	528,245
Short % of Shares Out	5.04%
Short % of Float	5.07%
Short Ratio (days to cover)	2.57

Income Statement

Revenue	n/a
Gross Profit	-4.62M
Operating Income	-9.22M
Pretax Income	-8.70M
Net Income	-8.70M
EBITDA	-9.22M
EBIT	-9.22M
Earnings Per Share (EPS)	-$1.45

Balance Sheet

The company has $21.03 million in cash and n/a in debt, with a net cash position of $21.03 million or $1.81 per share.

Cash & Cash Equivalents	21.03M
Total Debt	n/a
Net Cash	21.03M
Net Cash Per Share	$1.81
Equity (Book Value)	20.15M
Book Value Per Share	1.73
Working Capital	20.14M

Cash Flow

In the last 12 months, operating cash flow was -$7.98 million and capital expenditures -$12,000, giving a free cash flow of -$7.99 million.

Operating Cash Flow	-7.98M
Capital Expenditures	-12,000
Depreciation & Amortization	3,000
Net Borrowing	n/a
Free Cash Flow	-7.99M
FCF Per Share	-$0.69

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

PHIO does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-659.91%
Shareholder Yield	-659.91%
Earnings Yield	-59.42%
FCF Yield	-54.59%

Analyst Forecast

The average price target for PHIO is $10.67, which is 746.83% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$10.67
Price Target Difference	746.83%
Analyst Consensus	Strong Buy
Analyst Count	3
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on July 5, 2024. It was a reverse split with a ratio of 1:9.

Last Split Date	Jul 5, 2024
Split Type	Reverse
Split Ratio	1:9

Scores

Altman Z-Score	n/a
Piotroski F-Score	2